| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials. | Lancet | 2010 | 2.63 |
| 2 | Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals. | J Antimicrob Chemother | 2011 | 1.06 |
| 3 | CD4 cell count changes in individuals with counts above 500 cells/mm and viral loads below 50 copies/ml on antiretroviral therapy. | AIDS | 2002 | 0.94 |
| 4 | A step ahead on the HIV collaboratory. | Science | 2009 | 0.77 |
| 5 | Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives? | AIDS Res Ther | 2009 | 0.76 |
| 6 | Selected topics from the 10th Conference on Retroviruses and Opportunistic Infections. | HIV Clin Trials | 2003 | 0.75 |